Medical News

RSS

Creative art therapy combined with MBSR program shows promise for women with breast cancer

Cancer and stress go hand-in-hand, and high stress levels can lead to poorer health outcomes in cancer patients. The Jefferson-Myrna Brind Center of Integrative Medicine combined creative art therapy with a Mindfulness-based Stress Reduction (MBSR) program for women with breast cancer and showed changes in brain activity associated with lower stress and anxiety after the eight-week program.

29 Nov 2012

WellStar Health System implements Xenex’s room disinfection system

WellStar Health System was the first to implement and is the only health system in metro-Atlanta using Xenex Healthcare Services' room disinfection system in its patient and operating rooms. A "green," mercury-free technology, the Xenex system is the fastest, safest and most effective method for the advanced cleaning of hospital rooms, scientifically proven to destroy all major classes of microorganisms that cause hospital acquired infections (HAIs), such as MRSA and Clostridium difficile (C. diff).

29 Nov 2012

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

UCB, a global biopharmaceutical company focusing on CNS and immunology treatment and research, is sponsoring key sets of VIMPAT® (lacosamide) C-V data at the 66th Annual Meeting of the American Epilepsy Society (AES) in San Diego, Calif., November 30 - December 4.

29 Nov 2012

CEL-SCI's Multikine cancer drug receives key Japanese patent

CEL-SCI Corporation today announced that the Japanese patent office has issued a key patent covering CEL-SCI's investigational cancer drug, Multikine (Leukocyte Interleukin, Injection).

29 Nov 2012

Rexahn intends to offer shares of common stock and warrants

Rexahn Pharmaceuticals, Inc. today announced that it intends to offer shares of its common stock and warrants to purchase common stock in an underwritten public offering.

29 Nov 2012

FDA approves Velomedix’s IDE to expand design of VELOCITY trial for heart attack

Velomedix, Inc., a venture-backed medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to expand the design of its VELOCITY pilot clinical trial.

29 Nov 2012

Musical Moments for MS honors Kessler Foundation expert with Medical Excellence Award

John DeLuca, PhD, Vice President for Research and Training at Kessler Foundation, was named this year's recipient of the Medical Excellence Award by Musical Moments for MS. Dr. DeLuca will be honored at the 10th Anniversary of Musical Moments for MS on Tuesday, December 11 at NJPAC in Newark, NJ.

29 Nov 2012

IL17RC-mediated immune responses can be crucial in causing AMD

Changes in how genes in the immune system function may result in age-related macular degeneration (AMD), the leading cause of visual impairment in older adults, based on preliminary research conducted by National Institutes of Health (NIH) investigators.

29 Nov 2012

China's SFDA approves QIAGEN careHPV Test and instrument platform

QIAGEN N.V. today announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test and instrument platform.

From QIAGEN Manchester Limited 29 Nov 2012

Ginger.io announces $6.5M Series A funding

Ginger.io, the behavioral health analytics startup, today announced a $6.5 million Series A funding round led by Khosla Ventures.

29 Nov 2012

Omega-3 fatty acids can benefit women at risk of postpartum depression

The "feel-good" hormone serotonin, depleted by pregnancy, can be replenished by adding sources of omega-3 to the diets of pregnant women and new mothers - a development particularly beneficial to the 10 to 15 percent of women at risk for postpartum depression, according to a recent University of Montreal study published in the latest edition of the Canadian Journal of Psychiatry.

29 Nov 2012

$ACE-inhibitors, angiotensin receptor blockers can treat heart failure with preserved ejection fraction$

ACE-inhibitors, angiotensin receptor blockers can treat heart failure with preserved ejection fraction

A novel study from Karolinska Institutet in Sweden suggests that commonly used drugs to treat heart failure and high blood pressure may have a wider range of application than earlier known, and also can be used against so called HFPEF - a type of heart failure that until now has been impossible to treat.

29 Nov 2012

Pfizer completes acquisition of NextWave Pharmaceuticals

Pfizer Inc. today announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focused on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD).

29 Nov 2012

NovImmune commences NI-0101 Phase I clinical trial in arthritis

NovImmune SA initiated dosing in a Phase I clinical trial of NI-0101, a monoclonal antibody drug candidate targeting toll-like receptor-4 (TLR4).

29 Nov 2012

Forest, Alkem and Torrent settle generic BYSTOLIC patent infringement litigation

Forest Laboratories, Inc. and Forest Laboratories Holdings, Ltd. announced today that they have entered into settlement agreements with Alkem Laboratories, Ltd., Indchemie Health Specialties Pvt. Ltd., and Torrent Pharmaceuticals Ltd. and Torrent Pharma Inc. in patent infringement litigation brought by Forest in response to abbreviated new drug applications (ANDAs) filed by Alkem, Indchemie and Torrent each seeking approval to market generic versions of Forest's BYSTOLIC (nebivolol) tablets.

29 Nov 2012

NuFACE receives FDA clearance for Trinity Facial Toning Device

NuFACE is thrilled to announce the launch the FDA cleared Trinity Wrinkle Remover, a red light attachment for the NuFACE Trinity Facial Toning Device. The removable attachment is engineered with advanced LEDs to deliver a precise combination of red and infrared light therapy treatments to reduce full face wrinkles.

29 Nov 2012

Vermillion’s OVA1 diagnostic test effectively identifies early-stage ovarian cancer

Gynecologic Oncology, the prestigious medical journal of the Society for Gynecologic Oncology, has published the second prospective clinical study of OVA1 which demonstrated the positive performance of the multi-biomarker test in the triage of early-stage ovarian cancer.

29 Nov 2012

Roundup: Big insurance premium hikes sought in Calif., Conn.; Lawsuit alleges state regulators pad nursing home profits

California's largest for-profit health insurer, Anthem Blue Cross, is seeking to raise rates an average of 18 percent for more than 630,000 individual policyholders, drawing scrutiny from regulators and the ire of consumers already struggling with soaring premiums. Some Anthem customers may see rates rise as much as 25 percent in February under the company's proposal at a time when medical inflation is running at historic lows nationwide.

29 Nov 2012

Cancer-related fatigue and exercise: an interview with Dr Fiona Cramp

It is likely that there is more than one reason why people with cancer experience fatigue. The causes are likely to include side effects of the treatment that people are receiving for cancer as well as the direct effects of the cancer.

28 Nov 2012

Macular pigment screener launched by Elektron Technology

Elektron Technology is launching a new, easy-to-use macular pigment screener (MPS II) that can quickly identify those most at risk of developing age-related macular degeneration (AMD).

28 Nov 2012

Medical News

Creative art therapy combined with MBSR program shows promise for women with breast cancer

WellStar Health System implements Xenex’s room disinfection system

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

CEL-SCI's Multikine cancer drug receives key Japanese patent

Rexahn intends to offer shares of common stock and warrants

FDA approves Velomedix’s IDE to expand design of VELOCITY trial for heart attack

Musical Moments for MS honors Kessler Foundation expert with Medical Excellence Award

IL17RC-mediated immune responses can be crucial in causing AMD

China's SFDA approves QIAGEN careHPV Test and instrument platform

Ginger.io announces $6.5M Series A funding

Omega-3 fatty acids can benefit women at risk of postpartum depression

ACE-inhibitors, angiotensin receptor blockers can treat heart failure with preserved ejection fraction

Pfizer completes acquisition of NextWave Pharmaceuticals

NovImmune commences NI-0101 Phase I clinical trial in arthritis

Forest, Alkem and Torrent settle generic BYSTOLIC patent infringement litigation

NuFACE receives FDA clearance for Trinity Facial Toning Device

Vermillion’s OVA1 diagnostic test effectively identifies early-stage ovarian cancer

Roundup: Big insurance premium hikes sought in Calif., Conn.; Lawsuit alleges state regulators pad nursing home profits

Cancer-related fatigue and exercise: an interview with Dr Fiona Cramp

Macular pigment screener launched by Elektron Technology

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News